ÖZKAN, M. 2011. Phase II study of lapatinib in combination with ErbB2-amplified recurrent or metastatic breast cancer. J Clin Oncol 29 (suppl). Annual Meeting of American Society of Clinical Oncology , (Chicago, United States Of America).

ÖZKAN, M., (2011). Phase II study of lapatinib in combination with ErbB2-amplified recurrent or metastatic breast cancer . J Clin Oncol 29 (suppl). Annual Meeting of American Society of Clinical Oncology, Chicago, United States Of America

ÖZKAN, METİN. "Phase II study of lapatinib in combination with ErbB2-amplified recurrent or metastatic breast cancer," J Clin Oncol 29 (suppl). Annual Meeting of American Society of Clinical Oncology, Chicago, United States Of America, 2011

ÖZKAN, METİN. "Phase II study of lapatinib in combination with ErbB2-amplified recurrent or metastatic breast cancer." J Clin Oncol 29 (suppl). Annual Meeting of American Society of Clinical Oncology , Chicago, United States Of America, 2011

ÖZKAN, M. (2011) . "Phase II study of lapatinib in combination with ErbB2-amplified recurrent or metastatic breast cancer." J Clin Oncol 29 (suppl). Annual Meeting of American Society of Clinical Oncology , Chicago, United States Of America.

@conferencepaper{conferencepaper, author={METİN ÖZKAN}, title={Phase II study of lapatinib in combination with ErbB2-amplified recurrent or metastatic breast cancer}, congress name={J Clin Oncol 29 (suppl). Annual Meeting of American Society of Clinical Oncology}, city={Chicago}, country={United States Of America}, year={2011}}